Catalyst Pharmaceutical Partners (CPRX)

[DonShimoda]

Last year Lundbeck received FDA approval of Sabril (vigabatrin)for the treatment of infantile spasms. It's still way too early to know but if CPP-115 turns out to have a better safety profile, which would you want your child to have? At some point I would think that Lundbeck would consider acquiring Catalyst in order to protect its own vigabatrin franchise.